A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response
Open Access
- 3 March 2016
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 29 (3), 407-422
- https://doi.org/10.1016/j.ccell.2016.02.002
Abstract
No abstract availableKeywords
Funding Information
- Innovative Medicines Initiative Joint Undertaking (115188)
- EU-FP7
- EFPIA
- Swiss Cancer Research Foundation
- SNF
This publication has 59 references indexed in Scilit:
- The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domainProceedings of the National Academy of Sciences of the United States of America, 2012
- Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisationBritish Journal of Cancer, 2012
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenograftsBreast Cancer Research and Treatment, 2011
- A refined molecular taxonomy of breast cancerOncogene, 2011
- Human primary ductal carcinoma in situ (DCIS) subtype‐specific pathology is preserved in a mouse intraductal (MIND) xenograft modelThe Journal of Pathology, 2011
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast CancerCancer Cell, 2011
- Annexin A1 regulates TGF-β signaling and promotes metastasis formation of basal-like breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2010
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProceedings of the National Academy of Sciences of the United States of America, 2009
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006